600518 ST康美藥業
按盤價 
2.000 +0.070 (+3.627%) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.465 | -31.860 | -2,597.984 | -622.990 | -20.046 |
| 總資產報酬率 ROA (%) | 0.696 | -17.219 | 32.069 | -55.032 | -6.768 |
| 投入資產回報率 ROIC (%) | 1.107 | -27.004 | 50.079 | -143.838 | -8.581 | 邊際利潤分析 |
| 銷售毛利率 (%) | 17.067 | 15.143 | 16.044 | 3.427 | 13.197 |
| 營業利潤率 (%) | 1.778 | -42.523 | 243.488 | -563.393 | -33.804 |
| 息稅前利潤/營業總收入 (%) | 2.821 | -62.754 | 222.028 | -532.911 | -18.599 |
| 淨利潤/營業總收入 (%) | 2.125 | -64.443 | 190.725 | -574.575 | -40.673 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -18.667 | 26.638 | -29.026 | 13.464 | 76.873 |
| 價值變動淨收益/利潤總額(%) | 40.229 | -0.028 | 2.315 | 0.015 | -17.483 |
| 營業外收支淨額/利潤總額(%) | 21.474 | 33.277 | -23.979 | 1.748 | 11.888 | 償債能力分析 |
| 流動比率 (X) | 1.455 | 1.357 | 1.675 | 0.796 | 1.690 |
| 速動比率 (X) | 0.890 | 0.851 | 1.029 | 0.551 | 0.561 |
| 資產負債率 (%) | 50.418 | 53.959 | 37.908 | 131.236 | 68.026 |
| 帶息債務/全部投入資本 (%) | -3.692 | -4.313 | -4.210 | -- | 59.570 |
| 股東權益/帶息債務 (%) | -2,069.085 | -1,733.971 | -2,220.407 | -34.540 | 64.408 |
| 股東權益/負債合計 (%) | 97.884 | 84.895 | 163.111 | -24.090 | 46.694 |
| 利息保障倍數 (X) | 5.070 | -64.237 | 8.661 | -13.156 | -0.941 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 147.504 | 143.032 | 163.071 | 0.000 | 153.213 |
| 存貨周轉天數 (天) | 240.218 | 301.709 | 459.708 | 0.000 | 1,182.278 |
| 備註： | 即時報價更新時間為 26/04/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
